DePuy Synthes' spine imaging system earns FDA clearance

Spinal Tech

DePuy Synthes received FDA 510(k) clearance for its minimally invasive spine platform, Teligen, the devicemaker said Oct. 20.

Teligen was cleared for minimally invasive transforaminal lumbar interbody fusion, according to a news release. The system delivers technologies including camera controls, a VueLIF-T procedure kit, a Teligen clear discectomy device and patient-based disposable ports.

Teligen integrates with the Unleash family of implants, which are designed to streamline the main stages of MIS-TLIF.

The system is expected to be available later in 2022. DePuy Synthes is the orthopedics company for Johnson & Johnson.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers